Atlas Trials

Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia

Clinical trial NCT05926063 · UNKNOWN

Trial details

NCT number
NCT05926063
Sponsor
Universitaire Ziekenhuizen KU Leuven
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Neutropenia, Febrile
Start date
2024-02-26
Primary completion
2026-07-01
Enrollment
410

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.